Lexology November 26, 2024
Latham & Watkins LLP

Click here to watch the audio

CMS sought far-reaching changes to the Medicaid Drug Rebate Program in its 2023 proposed rule implementing the Medicaid Services Investment and Accountability Act. Find out which proposals CMS dropped from the final rule, and which changes became effective November 19, 2024.

The Centers for Medicare & Medicaid Services (CMS) recently published its final rule to implement the Medicaid Services Investment and Accountability Act of 2019 (MSIAA). The final rule significantly deviates from the agency’s 2023 proposal, with CMS backing off from “follow the pill” best price stacking, subjecting certain vaccines to Medicaid rebates, and creating a “shame list” of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Conferences / Podcast, Govt Agencies, Insurance, Medicaid, Trends
Where US hospitals stand on value of heart attack care: 5 things to know
ACA enrollment breaks records again in 2025
Getting ready for the new Five-Star ratings
CMS issues flurry of Medicare fines to payers
ACP expresses support for proposed Medicare $2 Drug List Model

Share This Article